A launch can make a rep's year, or be fumbled. How to prepare with data and target mapping, build a segmented plan, execute through first cases, and sustain adoption after launch.

The short version
- A launch concentrates opportunity in a short window; early momentum compounds and early stumbles are hard to undo.
- Prepare by mastering the clinical data and differentiators, then mapping the accounts, KOLs, and competition.
- Build a segmented, sequenced plan that wins early adopters and KOLs first, since peers influence peers.
- Execute with tight in-services, evaluations, and personally supported first cases, because early experiences set the reputation.
- Sustain by converting trials into standing business, defending the wins, and expanding from your early beachhead.
A launch is a rep's chance to plant a flag. A new product, especially a differentiated one, can reset your standing in a territory and make your year, but only if you run it well. Launches reward preparation and punish improvisation more than almost anything else in the job.
The reps who win launches treat them as a campaign, not a scramble. Here is how to run one from preparation through sustained adoption.
01Why do launches make or break a year?
Because a launch concentrates opportunity and attention in a short window. There is often pent-up demand, a competitive gap to exploit, and company resources and spotlight behind you, which rarely align this way in normal selling. Reps who capitalize can post a breakout year and establish themselves as the go-to for a new technology.
The flip side is that launches are unforgiving. Early momentum compounds, and so does early stumbling. If competitors get their version established while you are still figuring out your message, that gap is hard to close later. The window is real, and how you use the first stretch tends to set the trajectory.
02How do you prepare for a launch?
Master the product and the data before you sell a thing. Know the clinical evidence, the differentiators, and the objections cold, because a launch audience of physicians will test whether you actually understand what you are selling. Half-preparation shows immediately and costs you credibility right when it matters most.
Then map your targets. Identify the accounts and physicians most likely to adopt early, the key opinion leaders whose adoption influences others, and the competitive situation in each. A launch is not a spray-and-pray; it is a prioritized push at the customers who will move first and bring others with them.
03How do you build the launch plan?
Segment and sequence. Group your accounts by likelihood and influence: the early adopters and KOLs to win first, the fast followers to bring next, and the harder accounts for later. Then sequence your effort so your early energy goes where it creates references and momentum, because in medicine peers influence peers, and an influential early adopter is worth many cold pitches.
Build the plan account by account: who you are targeting first, what each needs to say yes, an evaluation, data, a peer's experience, and a realistic timeline. A launch run on a plan looks like a campaign. A launch run on enthusiasm alone looks busy and converts slowly.
04How do you execute the launch?
Get the product into hands and cases. Run tight in-services so the clinical team is comfortable, set up evaluations that let the product prove itself, and support the first cases personally, because early experiences make or break adoption. A flawless first case creates an advocate; a rough one creates a story that follows the product.
Be present and responsive during this window in a way you cannot be forever. Early adopters are taking a risk on something new, so make that risk feel safe: be there, answer fast, and solve problems before they grow. The reputation the product earns in its first cases is the reputation it carries.
05How do you sustain momentum after the launch?
Convert and defend. Turn evaluations and trials into standing business by following up while the experience is fresh, and do not let a successful first case drift back to the incumbent through neglect. The launch is not won at the first yes; it is won when the product becomes the default.
Then expand from your beachhead. Use your early adopters as references to win the fast followers, and let the momentum build account by account. A launch handled this way does not just spike and fade. It establishes a franchise in your territory that pays off long after the launch spotlight moves on.
Frequently Asked Questions
How do you launch a new medical device in your territory?
Prepare by mastering the clinical data and mapping your target accounts and KOLs, build a segmented plan that wins early adopters first, execute with in-services, evaluations, and well-supported first cases, then sustain momentum by converting trials and expanding from early references.
Why are product launches important in medical sales?
A launch concentrates pent-up demand, a competitive gap, and company resources into a short window, letting a rep post a breakout year and own a new technology. Early momentum compounds, so how you use the opening stretch tends to set the product's trajectory in your territory.
Who should you target first in a product launch?
Early adopters and key opinion leaders, the physicians most likely to try something new and whose adoption influences their peers. Winning influential early users first creates references and momentum that make the fast followers far easier to convert.
How do you make a product launch stick?
Convert evaluations and trials into standing business by following up while the experience is fresh, defend early wins from the incumbent, and expand from your early adopters using them as references. A launch is won when the product becomes the default, not at the first yes.
About This Series
This piece is part of The Lobby’s series on how the medical sales business actually works, built from practitioner accounts and the reps who do it well.
Want to carry a launch? Set your parameters once on The Lobby and let matching roles come to you.
